Document:

Filed by Bowne Pure Compliance

 

Ex. 10.72

SYNTROLEUM CORPORATION

2005 STOCK INCENTIVE PLAN

EMPLOYEE RESTRICTED STOCK AWARD AGREEMENT

THIS AGREEMENT
(“Agreement”), made as of the 20th day of December 2007 (the
“Grant Date”), evidences an award by Syntroleum Corporation, a
Delaware corporation (the “Company”) to Richard L. Edmonson (the
“Grantee”) pursuant to the 2005 Stock Incentive Plan (the
”Plan”). Capitalized terms used and not otherwise defined herein
shall have the meaning ascribed thereto in the Plan.

1. Grant of
Restricted Stock Award. Effective as of the Grant Date, pursuant to
Section 8 of the Plan, the Company has awarded to the Grantee a Restricted
Stock Award with respect to one hundred thousand (100,000) shares of Common
Stock, subject to the conditions and restrictions set forth below and in the
Plan (the “Restricted Stock”).

2. Restrictions. The Restricted Stock granted
hereunder to the Grantee may not be sold, assigned, transferred, pledged or
otherwise encumbered from the Grant Date until the date that the Grantee
obtains a vested right to the shares (and the restrictions thereon terminate)
in accordance with the provisions of this Section 2. Out of the Restricted
Stock grant described in Section 1, above, upon the completion of each of
the following events, as determined by the Nominating and Compensation
Committee of the Company’s Board of Directors (the
“Committee”) in its discretion:

	 	(a)	 	
upon the execution of the Waiver and Release
pursuant to the Separation Agreement dated December 20, 2007 between the
Company and Grantee and the expiration of the seven day revocation period,
Grantee shall have a vested right to thirty-three thousand (33,000) of the
shares of Restricted Stock; and

	 	(b)	 	
upon the date of closing of all of the
financing for the construction of a plant of capacity to produce of at least
3000 barrels per day of sales product (the “Plant”), Grantee shall
have a vested right to thirty-three thousand (33,000) of the shares of
Restricted Stock; and

	 	(c)	 	
upon the date of completion of start-up
operations and commencement of the Plant’s commercial operations, Grantee
shall have a vested right to the remaining thirty-four thousand (34,000) of the
 shares of Restricted Stock.

1

1

 

Notwithstanding the foregoing,
Grantee shall have a vested right to all of the Restricted Stock upon a Change
in Control.

To the extent any of the shares of
Restricted Stock have not vested as of March 16, 2012, such unvested
shares shall be forfeited.

The period of time between the Grant
Date and the date that the Grantee obtains a vested right to the Restricted
Stock shall be referred to herein as the “Restricted Period” as to
those shares. In the event that any day on which the Grantee would otherwise
obtain a vested right to the Restricted Stock is a Saturday, Sunday or holiday,
the Grantee shall instead obtain that vested right on the first business day
immediately following such date.

3. Share
Issuance. The Company will issue to Grantee stock certificates evidencing
the shares of Restricted Stock, which certificates will be registered in the
name of Grantee and will bear an appropriate legend referring to the terms,
conditions, and restrictions applicable to the Restricted Stock, substantially
in the following form:

The transferability of this certificate and the shares of
Common Stock represented hereby are subject to the terms, conditions and
restrictions (including forfeiture) contained in the Employee Restricted Stock
Award Agreement, effective as of December 20, 2007, between Syntroleum
Corporation and the registered owner hereof. Copies of such Agreement are on
file in the offices of Syntroleum Corporation, 4322 South 49th West Avenue,
Tulsa, Oklahoma, 74107.

The certificates evidencing the
shares of Restricted Stock shall be held in custody by the Company or, if
specified by the Committee, by a third party custodian or trustee, until the
restrictions on such shares shall have lapsed, and, as a condition of this
award of Restricted Stock, the Grantee shall deliver a stock power, duly
endorsed in blank, relating to the shares of Restricted Stock. Upon the vesting
and expiration of the restrictions as to any portion of the Restricted Stock,
the Company will cause a new certificate evidencing such number of shares of
Common Stock to be delivered to the Grantee, or in the case of his death to his
Beneficiary, free of the legend regarding transferability; provided that the
Company shall not be obligated to issue any fractional shares of Common Stock.

2

2

 

4. Beneficiary Designations. Pursuant to
Section 10 of the Plan, the Grantee shall file with the Company on such
form as may be prescribed by the Company, a designation of one or more
beneficiaries and, if desired, one or more contingent beneficiaries (each
referred to herein as a “Beneficiary”) to whom shares of Common
Stock otherwise due the Grantee under the terms of this Agreement shall be
distributed in the event of the death of the Grantee. The Grantee shall have
the right to change the Beneficiary or Beneficiaries from time to time;
provided, however, that any change shall not become effective until received in
the Grantee’s handwriting by the Committee. If there is no effective
Beneficiary designation on file at the time of the Grantee’s death, or if
the designated Beneficiary or Beneficiaries have all predeceased such Grantee,
the payment of any remaining benefits under this Agreement shall be made to the
personal representative or executor of the Grantee’s estate. If one or
more but not all the Beneficiaries have predeceased such Grantee, the benefits
under this Agreement shall be paid according to the Grantee’s
instructions in his designation of Beneficiaries. If the Grantee has not given
instructions, or if the instructions are not clear, the benefits under this
Agreement which would have been paid to the deceased Beneficiary or
Beneficiaries will be paid to the personal representative or executor of
Grantee’s estate.

5. Nonalienation of Benefits. Except as
contemplated by Section 5 above, no right or benefit under this Agreement
shall be subject to transfer, anticipation, alienation, sale, assignment,
pledge, encumbrance or charge, whether voluntary, involuntary or by operation
of law, and any attempt to transfer, anticipate, alienate, sell, assign,
pledge, encumber or charge the same shall be void. No right or benefit
hereunder shall in any manner be liable for or subject to any debts, contracts,
liabilities or torts of the person entitled to such benefits. If the Grantee or
the Grantee’s Beneficiary hereunder shall become bankrupt or attempt to
transfer, anticipate, alienate, assign, sell, pledge, encumber or charge any
right or benefit hereunder, other than as contemplated by Section 5 above,
or if any creditor shall attempt to subject the same to a writ of garnishment,
attachment, execution, sequestration or any other form of process or
involuntary lien or seizure, then such right or benefit shall cease and
terminate.

6. Prerequisites to Benefits. Neither the
Grantee, nor any person claiming through the Grantee, shall have any right or interest
in Restricted Stock awarded hereunder, unless and until all the terms,
conditions and provisions of this Agreement and the Plan which affect the
Grantee or such other person shall have been complied with as specified herein.

3

3

 

7. Issuance
and Delivery of Shares. The Company shall not be obligated to issue or
deliver any shares of Common Stock if counsel to the Company determines that
such issuance or delivery would violate any applicable law or any rule or
regulation of any United States governmental authority or any rule or
regulation of, or agreement of the Company with, any securities exchange or
association upon which the Common Stock is listed or quoted. If necessary to
comply with any such law, rule, regulation or agreement, the Company shall in
no event be obligated to take any affirmative action in order to cause the
issuance or delivery of shares of Common Stock. If within 45 calendar days of
vesting all or portion of the Restricted Stock the Company does not issue the
Common Stock due Grantee, Company shall pay to Grantee, at Grantee’s
option, the equivalent value of the vested Restricted Stock. Equivalent cash
values shall be calculated as the highest five day rolling average price from
the vesting date to the vesting date plus 45 calendar days.

8. Rights
as a Stockholder. During the period in which the restrictions provided
herein are applicable to the Restricted Stock, the Grantee shall have the right
to vote the shares of Restricted Stock and to receive any cash dividends paid
with respect thereto unless and until forfeiture thereof. Any dividend or
distribution payable with respect to shares of Restricted Stock that shall be
paid or distributed in shares of Common Stock shall be subject to the same
restrictions provided for herein, and the shares so paid or distributed shall
be deemed Restricted Stock subject to all terms and conditions herein. Any
dividend or distribution (other than cash or Common Stock) payable or
distributable on shares of Restricted Stock, unless otherwise determined by the
Committee, shall be subject to the terms and conditions of this Agreement to
the same extent and in the same manner as the Restricted Stock is subject;
provided that the Committee may make such modifications and additions to the
terms and conditions (including restrictions on transfer and the conditions to
the timing and degree of lapse of such restrictions) that shall become
applicable to such dividend or distribution as the Committee may provide in its
absolute discretion.

9. Taxes. The Company shall have the right to
withhold an appropriate amount of cash or number of shares of Common Stock, or
combination thereof, for payment of taxes or other amounts required by law or
to take such action as may be necessary in the opinion of the Company to
satisfy all obligations for withholding of taxes. Withholding may be satisfied
by the transfer to the Company of shares of Common Stock theretofore owned by
the Grantee, subject to such terms and conditions as the Committee shall
prescribe.

10. Adjustments. As provided in the Plan,
certain adjustments may be made to the Restricted Stock upon the occurrence of events
or circumstances described in Section 19 of the Plan.

4

4

 

11. Notice. Unless the Company notifies the
Grantee in writing of a different procedure, any notice or other communication to the
Company with respect to this Agreement shall be in writing and shall be
delivered personally or by first class mail, postage prepaid to the following address:

Syntroleum Corporation

c/o Corporate Secretary

4322 South 49th West Avenue

Tulsa, Oklahoma 74107

Any notice or other communication to
the Grantee with respect to this Agreement shall be in writing and shall be
delivered personally, or shall be sent by first class mail, postage prepaid, to
Grantee’s address as listed in the records of the Company on the Grant
Date, unless the Company has received written notification from the Grantee of
a change of address.

12. Amendment. Without the consent of the
Grantee, this Agreement may be amended or supplemented (i) to cure any ambiguity or
to correct or supplement any provision herein which may be defective or
inconsistent with any other provision herein, or (ii) to add to the
covenants and agreements of the Company for the benefit of Grantee or to add to
the rights of the Grantee or to surrender any right or power reserved to or
conferred upon the Company in this Agreement, subject, however, to any required
approval of the Company’s stockholders and, provided, in each case, that
such changes or corrections shall not adversely affect the rights of Grantee
with respect to the Award evidenced hereby without the Grantee’s consent,
or (iii) to make such other changes as the Company, upon advice of
counsel, determines are necessary or advisable because of the adoption or
promulgation of, or change in or of the interpretation of, any law or
governmental rule or regulation, including any applicable federal or state
securities laws.

13. Grantee
Employment. Nothing contained in this Agreement, and no action of the
Company or the Committee with respect hereto, shall confer or be construed to
confer on the Grantee any right to continue as an employee of the Company.

14. Governing Law. This Agreement shall be
governed by, and construed in accordance with, the internal laws of the State of Oklahoma.

15. Construction. References in this Agreement
to “this Agreement” and the words “herein,”
“hereof,” “hereunder” and similar terms include the
Plan. The headings of the Sections of this Agreement have been included for
convenience of reference only, are not to be considered a part hereof and shall
in no way modify or restrict any of the terms or provisions hereof.

5

5

 

16. Relationship to the Plan. In addition to
the terms and conditions described in this Agreement, grants of Restricted Stock
are subject to all other applicable provisions of the Plan. The decisions of
the Committee with respect to questions arising as to the interpretation of the
Plan, or this Agreement and as to finding of fact, shall be final, conclusive
and binding.

SYNTROLEUM CORPORATION

By

	 	/s/ Edward G. Roth

	 	 
	 	Name: Edward G. Roth

	 	Title: President & Chief Executive Officer 

GRANTEE

	 	/s/ Richard L. Edmonson

	 	 
	 	Richard L. Edmonson

6

6EXHIBIT 10.1

EXHIBIT 10.1

SHARE PURCHASE AGREEMENT

This Agreement made as of the 15th day of December, 2007 (“Agreement”), by and between William Tay, with an address at 305 Madison Avenue, Suite 1166, New York, NY 10165 USA ("Seller"), and Dr. Leo H. Lin, with an address at c/o Dr. Leo H. Lin, Chairman Asia Pacific Technology & Intellectual Property Services, Inc., 11 Fl. 189 Gangcian Road, Neihu, Taipei 114, Taiwan, ROC ("Purchaser").

W I T N E S S E T H:

WHEREAS, Seller is the record owner and holder of 31,340,000 Common Shares, par value $.0001 par value (the “Shares”), of SKYTRIP HOLDINGS, INC., a Delaware corporation ("Corporation”), which Corporation has 31,340,000 shares of common stock, issued and outstanding as of the date of this Agreement, as more fully described in the attached Exhibit A.  

WHEREAS, Purchaser desires to purchase 30,713,200 of the Shares from Seller, which constitutes 98% of the Corporation’s issued and outstanding shares as of the date of this Agreement and Seller desires to sell such Shares upon the terms and conditions hereinafter set forth;   

NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and agreements contained in this Agreement, and in order to consummate the purchase and sale of the Corporation’s Shares, it is hereby agreed, as follows:

1.

PURCHASE AND SALE OF SHARES.  Subject to the terms and conditions of this Agreement, Purchaser agrees to purchase at the Closing and the Seller agrees to sell to Purchaser at the Closing, 30,713,200 of Seller’s Shares for a total price of Sixty-Nine Thousand Nine Hundred and 00/100 dollars ($69,900.00) (the “Purchase Price”).

2.

GOOD FAITH DEPOSIT.  On or before December 21, 2007, Purchaser agrees to wire transfer to an account to be designated by Seller, the sum of Six Thousand Nine Hundred Ninety and 00/100 dollars ($6,990.00) as an initial deposit to Seller.  At the Closing, as defined below, Purchaser will pay the balance of the Purchase Price, Sixty-Two Thousand Nine Hundred Ten and 00/100 dollars ($62,910.00) to Seller by wire transfer.

3.

CLOSING.  The purchase and sale of the Shares shall take place on or before January 15, 2008; at such time and place as the Purchaser and Seller mutually agree upon orally or in writing (which time and place are designated as the “Closing”).  At Closing, Purchaser shall deliver to Seller, in cash, by wire transfer to an account to be designated by Seller, the balance of the Purchase Price in the amount of Sixty-Two Thousand Nine Hundred Ten and 00/100 dollars ($62,910.00), and Seller will immediately deliver the following to Purchaser: (A) the certificates representing the Shares transferred hereunder, duly endorsed for transfer to the Purchaser or accompanied by appropriate stock powers, (B) the original of the Certificate of Incorporation and bylaws, (C) all corporate books and records (including all accounting records and SEC filings to date); and (D) written resignations of incumbent directors and officers of the Corporation.

4.

REPRESENTATIONS AND WARRANTIES OF SELLER.  Seller, as sole director and officer of Corporation, hereby represents and warrants to Purchaser that: 

(i)

Corporation is a corporation duly organized and validly existing and in good standing under the laws of the State of Delaware and has the corporate power and authority to carry on the business it is now being conducted.  Corporation and/or Seller do not require any consent and/or authorization, declaration or filing with any government or regulatory authority to undertake nay actions herein;

(ii)

Corporation has filed with the United States Securities and Exchange Commission (‘SEC”) a registration statement on Form 10-SB effective pursuant to the Securities Exchange Act of 1934 and is a reporting company pursuant to Section 12(g) thereunder.

(iii)

Corporation has timely filed and is current on all reports required to be filed by it pursuant to Sections 13 and 15 of the Securities Exchange Act of 1934.

(iv)

Corporation is newly formed with no financial information available other than the financial information included in its SEC filings; 

(v)

There are no legal actions, suits, arbitrations, or other administrative, legal or governmental proceedings threatened or pending against the Corporation and/or Seller or against the Seller or other employee, officer, director or stockholder of Corporation.  Additionally, Seller is not aware of any facts which may/might result in or form a basis of such action, suit, arbitration or other proceeding on any basis whatsoever; 

(vi)

The Corporation has no subsidiaries or any direct or indirect ownership interest in any other corporation, partnership, association, firm or business in any manner;

(vii)

The Corporation and/or Seller does not have in effect nor has any present intention to put into effect any employment agreements, deferred compensation, pension retirement agreements or arrangements, options arrangements, bonus, stock purchase agreements, incentive or profit–sharing plans; 

(viii)

No person or firm has, or will have, any right, interest or valid claim against the Corporation for any commission, fee or other compensation in connection with the sale of the Shares herein as a finder or broker or in any similar capacity as a result of any act or omission by the Corporation and/or Seller or anyone acting on behalf of the Corporation and/or Seller;

(ix)

The business and operation of the Corporation has and will be conducted in accordance with all applicable laws, rules, regulations, judgments.  Neither the execution, delivery or performance of this Agreement (A) violates the Corporation’s by-laws, Certificate of Incorporation, Shareholder Agreements or any existing resolutions; and, (B) will cause the Corporation to lose any benefit or any right or privilege it enjoys under the Securities Act (“Act”) or other applicable state securities laws;  

(x)

Corporation has not conducted any business and/or entered into any agreements with third-parties; 

(xi)

This Agreement has been duly executed and delivered by constitutes a valid and binding instrument, enforceable in accordance with its terms and does not conflict with or result in a breach of or in violation of the terms, conditions or provisions of any agreement, mortgage, lease or other instrument or indenture to which Corporation and/or Seller a party or by which they are bound; 

(xii)

Seller is the legal and beneficial owner of the Shares and has good and marketable title thereto, free and clear of any liens, claims, rights and encumbrances;

(xiii)

Seller warrants that the Corporation being transferred shall be transferred with no liabilities and little or no assets, and shall defend and hold Purchaser and the Corporation harmless against any action by any third party against either of them arising out of, or as a consequence of, any act or omission of Seller or the Corporation prior to, or during the closing contemplated by this contract of sale; and,

(xiv)

The information contained on Exhibit A is true and correct.  

5.

REPRESENTATIONS AND WARRANTIES OF PURCHASER.  Purchaser hereby represents and warrants to Seller that:  

(i)

Purchaser has the power and authority to execute and deliver this Agreement, to perform his obligations hereunder and to consummate the transactions contemplated hereby. This Agreement has been duly executed and delivered by Purchaser and constitutes a valid and binding instrument, enforceable in accordance with its terms;

(ii)

The execution, delivery and performance of this Agreement is in compliance with and does not conflict with or result in a breach of or in violation of the terms, conditions or provisions of any agreement, mortgage, lease or other instrument or indenture to which Purchaser is a party or by which Purchaser is bound;

(iii)

At no time was Purchaser presented with or solicited by or through any leaflet, public promotional meeting, television advertisement or any other form of general solicitation or advertising; and,

(iv)

Purchaser is purchasing the Shares solely for his own account for the purpose of investment and not with a view to, or for sale in connection with, any distribution of any portion thereof in violation of any applicable securities law.

(v)

The Purchaser is an "accredited investor" as defined under Rule 501 under the Securities Act.

(vi)

Purchaser hereby agrees that such shares are restricted pursuant to Rule 144 and therefore subject to Rule 144 resale requirements.  

6.

NOTICES.  Notice shall be given by certified mail, return receipt requested, the date of notice being deemed the date of postmarking. Notice, unless either party has notified the other of an alternative address as provided hereunder, shall be sent to the address as set forth herein:

Seller:

William Tay, President & Dir.

Skytrip Holdings, Inc.

305 Madison Avenue, Suite 1166

New York, NY 10165

FAX: (917) 591-2648

Purchaser:

Dr. Leo H. Lin

Chairman Asia Pacific Technology & Intellectual Property Services, Inc.

11 Fl. 189 Gangcian Road,

Neihu, Taipei 114, Taiwan, ROC

7.

GOVERNING LAW.  This Agreement shall be interpreted and governed in accordance with the laws of the State of Delaware.   The parties herein waive trial by jury.  In the event that litigation results or arise out of this Agreement or the performance thereof, the parties agree that the prevailing party is entitled to reimbursement for the non-prevailing party of reasonable attorney’s fee, costs, expenses, in addition to any other relief to which the prevailing party may be entitled.

8.

CONDITIONS TO CLOSING.  The Closing is conditioned upon the fulfillment by the Seller of the satisfaction of the representations and warranties made herein being true and correct in all material respects as of the date of Closing. 

9.

SEVERABILITY.  In the event that any term, covenant, condition, or other provision contained herein is held to be invalid, void or otherwise unenforceable by any court of competent jurisdiction, the invalidity of any such term, covenant, condition, provision or Agreement shall in no way affect any other term, covenant, condition or provision or Agreement contained herein, which shall remain in full force and effect.  

10.

ENTIRE AGREEMENT.  This Agreement contains all of the terms agreed upon by the parties with respect to the subject matter hereof. This Agreement has been entered into after full investigation.  

11.

INVALIDITY.  If any paragraph of this Agreement shall be held or declared to be void, invalid or illegal, for any reason, by any court of competent jurisdiction, such provision shall be ineffective but shall not in any way invalidate or effect any other clause, Paragraph, section or part of this Agreement.  

12.

GENDER AND NUMBER; SECTION HEADINGS.  Words importing a particular gender mean and include the other gender and words importing a singular number mean and include the plural number and vice versa, unless the context clearly indicated to the contrary.  The section and other headings contained in this Agreement are for reference purposes only and shall not affect the meaning or interpretation of this Agreement.  

13.

AMENDMENTS.  No amendments or additions to this Agreement shall be binding unless in writing, signed by both parties, except as herein otherwise provided.  

14.

ASSIGNMENT.  Neither party may assign this Agreement without the express written consent of the other party.  Any agreed assignment by the Seller shall be effectuated by all the necessary corporate authorizations and governmental and/or regulatory filings.

15.

CLOSING DOCUMENTS.  Seller and Purchaser agree, at any time, to execute, and acknowledge where appropriate, and to deliver any and all documents/instruments, and take such further action, which may necessary to carry out the terms, conditions, purpose and intentions of this Agreement.  This paragraph shall survive the Closing.

16.

EXCLUSIVE AGREEMENT; AMENDMENT. This Agreement supersedes all prior agreements or understandings among the parties with respect to its subject matter with respect thereto and cannot be changed or terminated orally.

17. 

FACSIMILE SIGNATURES. Execution of this Agreement and delivery of signed copies thereof by facsimile signatures from the parties hereto or their agents is acceptable to the parties who waive any objections or defenses based upon lack of an original signature.

18.

PUBLICITY.   Except as otherwise required by law, none of the parties hereto shall issue any press release or make any other public statement, in each case relating to, connected with or arising out of this Agreement or the matters contained herein, without obtaining the prior approval of the other to the contents and the manner of presentation and publication thereof.

IN WITNESS WHEREOF, and intending to be legally bound, the parties hereto have signed this Agreement by their duly authorized officers the day and year first above written. 

/s/ Dr. Leo H. Lin

_________________________________

By: Dr. Leo H. Lin

(PURCHASER)

/s/ William Tay

_________________________________

By: William Tay

(SELLER)

EXHIBIT A

Skytrip Holdings, Inc.

A Delaware Corporation

Skytrip Holdings, Inc., a Delaware corporation (“Company”), is a fully SEC reporting company and its Common Stock is registered under the Securities Exchange Act of 1934, as amended.

The Company’s management believes that there are certain benefits of being a reporting public company, and that certain private company (domestic or foreign) may seek to gain these advantages through a reverse merger with the Company because its shares may thereby be quoted on the United States secondary markets such as the NYSE, NASDAQ, Amex, and the NASD OTC Bulletin Board (OTC-BB).

CORPORATE INFORMATION

	Legal Name of Public Shell:

	Skytrip Holdings, Inc.

	SEC FILE / CIK Numbers:

	000-52629 / 0001386977

	SEC Reporting Status:

	Public reporting, current in all SEC filings to date.

	SEC Form 10-SB Effective Date

	July 14, 2007

	State of Incorporation and Date of Formation:

	State of Delaware on January 9, 2007

	Net Equity:

	-0-

	Underwriter:

	Self

	Date of fiscal year-end:

	12/31

	Total and pending liabilities:

	None

STOCK INFORMATION

	Classes of Stock

	Preferred Stock, at $0.0001 par value

Common stock, at $0.0001 par value

	Authorized Capital Stock:

	Capitalization: 250,000,000 Common Shares

20,000,000 Preferred Shares

	Issued and Outstanding Shares:

	31,340,000 Common Shares

-0- Preferred Shares, none designated

	Warrants and Options Outstanding:

	None

	OTC-BB Trading Symbol:

	Form 211 (15c2-11) to be filed with NASD Regulations, Inc. (NASDAQ) through a sponsoring market maker upon consummation of business combination.

	Market Makers:

	To be appointed upon consummation of business combination.

	Transfer Agent and Registrar:

	It is anticipated that Holladay Stock Transfer, Inc. of Scottsdale, AZ will act as transfer agent for the Company's common stock. However, the Company may appoint a different transfer agent or act as its own until a merger candidate can be identified.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}]]